LINC03017: A Long Intergenic Non-Protein-Coding RNA and Its Potential as a Drug Target

Target Name: LINC03017

NCBI ID: G101927378

LINC03017

Other Name(s): Long intergenic non-protein coding RNA 3017, transcript variant 1 | Long intergenic non-protein coding RNA 3017, transcript variant 2 | long intergenic non-protein coding RNA 3017

LINC03017: A Long Intergenic Non-Protein-Coding RNA and Its Potential as a Drug Target

LINC03017 is a long intergenic non-protein-coding RNA (lncRNA) with a length of approximately 210 nucleotides. It is located between the intron 15 of HLA-DPZ gene and the exon 1 of the P24 gene on chromosome 6p12.3. LINC03017 is a non-coding RNA molecule that is not directly involved in protein production, but it plays a crucial role in the regulation of gene expression. The function of LINC03017 is not well understood, but it is considered as a potential drug target in the future.

Expression and Localization

LINC03017 is expressed in a variety of tissues and cells, including muscle, liver, and brain. It is also expressed in the placenta, which suggests that it may be involved in fetal development and growth. The protein encoded by LINC03017 is approximately 11 kDa and has been shown to localize to the nucleoplasm.

Function

LINC03017 is involved in the regulation of gene expression by binding to specific DNA sequences. It has been shown to interact with the protein coding for the heat shock protein (Hsp70), which is a protein that protects the cell from heat stress. LINC03017 has also been shown to interact with the protein coding for the tumor suppressor protein (Tsp1), which plays a role in cell growth and apoptosis.

Drug Target Potential

The potential drug target for LINC03017 is based on its function as a negative regulator of gene expression. Drugs that can inhibit the activity of LINC03017 may have therapeutic benefits for a variety of diseases. For example, LINC03017 has been shown to be involved in the regulation of muscle growth and development, which could make it a potential drug target for muscle-related diseases.

Additionally, LINC03017 has also been shown to be involved in the regulation of liver and brain development and function, which could make it a potential drug target for liver and brain-related diseases.

Conclusion

LINC03017 is a long intergenic non-protein-coding RNA that is expressed in a variety of tissues and cells. It is involved in the regulation of gene expression by binding to specific DNA sequences, including the heat shock protein (Hsp70) and the tumor suppressor protein (Tsp1). The potential drug target for LINC03017 is based on its function as a negative regulator of gene expression and its involvement in the regulation of muscle, liver, and brain development and function. Further research is needed to understand the full function of LINC03017 and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 3017

The "LINC03017 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC03017 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets